Biochemistry analyzers are clinical chemical analyzing devices which measures components in biological sample including blood urine, plasma. It uses many electrochemical and optical techniques to analyze blood, urine, cerebrospinal fluid and other biological samples. Function of these analyzers is mostly based on optical measurements which includes calorimetric, absorption, spectrometric and fluoroscopic detection.
These processes can measure chemicals such as antigens molecules and proteins in the body fluid. These analyzers are mostly used in hospitals, clinics, epidemic prevention stations. Biochemical analyzers are made up of optical engine which includes light source, detectors, and other optical elements. For greater accuracy biochemistry analyzers are highly automated. It automates sample loading tube cleaning mechanical control and data processing.
The user just needs to insert sample for analysis, choose the program and starts the instrument. These analyzers are not only used in medical field but also used in research industries and diagnosis of various diseases. Main aim of these analyzers is in medical field as they are safe to use in hospital laboratories. They are used to perform many tests like sugar test, albumin test.
Some of the key players for global biochemistry analyzers market are
The global market for biochemistry analyzers can be divided into two types: fully automated and semi-automated systems. Semi-automated systems, which are significantly more cost-effective, take up the majority of the market share by volume. These analyzers are typically used in small diagnostic labs with low sample volumes, such as in clinics or hospitals, while automated systems are used in larger labs with high sample volumes. The trend towards automation in the industry could lead to a faster growth in the market for automated analyzers.
The global biochemistry analyzers market is segmented by end-users into hospitals, diagnostic labs, research institutions, and others. Diagnostic labs account for the largest revenue share in the market due to the high capital costs associated with the installation of these machines. However, hospitals are expected to be the fastest-growing segment during the forecast period as a result of the demand for faster results, along with the increasing availability of small-scale and point-of-care analyzers.
The global market for biochemistry analyzers is divided into floor-standing and bench-top analyzers. Floor-standing analyzers are the largest revenue generators, while bench-top analyzers account for the highest volume. Floor-standing analyzers are bigger and faster than bench-top analyzers, but they are more expensive and their size restricts them to core diagnostic laboratories.
The global biochemistry analyzers market is segmented into North America, Europe, Asia-Pacific Latin America, and Middle East & Africa. North America is expected to dominate the market within the forecast period attributed to key players launching new biochemistry analyzers for diagnosis purpose and highly developed healthcare industry in this region.
Biochemistry analyzers are used to analyze, to detect and to determine various functions of biomolecules within the cell. Analyzing biomolecules is important for disease diagnostics, food safety inspection and pharmaceutical development. Europe is projected to capture the second largest share of global biochemistry analyzers market due to growing geriatric population, rising prevalence of chronic diseases, and increasing number of product offerings in this region. For example; in November 2019, JEOL.LTD launched its biomajesty series of chemistry analyzers which includes JCA-ZS050, JCA-BM6070/C and JCA-BM6010/C.
Covid-19 has shown a positive impact on global biochemistry analyzer market due increased demand of laboratory tests to diagnose and monitor Covid-19. So that demand of global biochemistry market is increased.
However, limited tests used in the diagnosis and monitoring of COVID-19, delay of non-urgent health issues because of the pandemic and decrease in the number of patients due to concern of contagion have led to a drop in test numbers which has affected the market growth up to some extent.
As biochemistry analyzers also known as clinical chemistry analyzers, they are used to measure metabolites present in biological samples like blood urine. By studying these samples, it is possible to diagnose many diseases. In addition, increasing number of product launches in this field is also supplementing the market growth. For instance; in September 2020, Agappe diagnostics launched a new hematology analyzer.
In addition, growing number of cases of chronic diseases is also propelling the growth of the market. As there are number of cases of chronic diseases increasing, there is more demand of analyzers to detect the body biomolecules. Aging population and changes in societal behavior causes steady increase in these chronic diseases.
For example; according to international federation (IDF), 463 million people worldwide had diabetes in 2019, a 62% increase since 2009. Therefore, to detect these chronic diseases by using body fluids there is increasing demand of analyzers which boosts the growth of the market.
The introduction of the new biochemistry analyzers has significantly improved the efficiency of sample analysis, as it has reduced the number of reagents used and the time needed to complete repetitive tasks. Furthermore, the automation of sample analysis has improved the accuracy of results, as it eliminates the potential for human error. Finally, the use of discrete systems has increased the safety of lab technicians, as it reduces the amount of exposure to hazardous reagents.
|Historical data||2015 - 2020|
|Forecast Period||2022 - 2028|
|Market Size in 2021:||USD 3.53 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 5.18 Billion|
|Tables, Charts & Figures:||175|
|Key Players/Companies||Abbott, Danaher, F. Hoffmann-La-Roche Ltd., Meril Life Science Pvt. Ltd., Siemens AG, Hologic, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Beckman Coulter, Inc., Horiba Ltd, Erba , Microlab, RMS, Mindray, others.|
|Segments Covered||By Type, By End-Users, By Configuration|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|